Role of Axonal and Somatodendritic Monoamine Transporters in Action of Uptake Blockers
- 1 January 1997
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric studyPublished by Elsevier ,2003
- Cocaine effects on brain noradrenergic neurons of anesthetized and unanesthetized ratsNeuropharmacology, 1993
- Is there a significant somatodendritic uptake of dopamine in the substantia nigra? Evidence from the weaver mutant mouseNeurochemistry International, 1993
- Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: A microdialysis studyLife Sciences, 1992
- Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortexBrain Research, 1992
- Autoradiographic localization of dopamine uptake sites in the rat brain with3H-GBR 12935Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
- Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatumLife Sciences, 1992
- Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporterNature, 1991
- Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: A structure-activity studyLife Sciences, 1990
- The involvement of 5-hydroxytryptamine in the release of dendritic dopamine from slices of rat substantia nigraJournal of Pharmacy and Pharmacology, 1983